| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.00041 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0005 | 1 |